The FDA is seeking tighter controls over antibacterial soap and body wash.
The FDA's advisory panel backed a new type of diabetes drug that was previously rejected due to safety concerns.
The FDA has warned consumers that the nipple aspirate test is not a confirmed, effective screening tool against breast cancer.
The Food and Drug Administration has asked global drugmakers and health companies to revise labels of medically-important antibiotics to remove references to use in animal production.
Nearly 2,000 students at the Ivy League waited in line to receive the imported emergency meningitis vaccine.
The FDA has approved Xiaflex as a treatment option for Peyronie's disease.
The FDA approved a new treatment for hepatitis C.
The FDA has issued safety protocols in regards to using recalled Philips Healthcare defibrillators.
FDA recently issued draft guidelines addressing food service and manufacturers to revise their methods for producing certain types of food. In the guidelines FDA has warned of the presence of possible cancer-causing chemical known as acrylamide.
The FDA has ordered 23andMe to stop selling its DNA tests because the company has not proven that its tests are accurate.
The U.S. Food and Drug Administration has approved the use of anti-cancer drug Nexavar (sorafenib) for late-stage differentiated thyroid cancer. The type is one of the most common kinds of thyroid cancer.
USPlabs has issued a voluntary recall of its OxyElite Pro products after they were tied to causing an outbreak of liver illnesses.
The FDA's new proposal will require drug companies that make life-saving drugs to inform the agency of any potential changes that could affect the U.S. supply six months prior to the changes.
The U.S. Food and Drug Administration reported that 12 percent of imported spices are contaminated with insects, animal excrement, rodent hair and rubber bands.
A new study published in JAMA found that in 2008, eight drugs where approved faster due to expedited review.
Researchers from the University of Sheffield School of Health and Related Research (ScHARR) are today making a series of recommendations for NHS mental health trusts to change the way they collect and use patient feedback to improve the quality of care for inpatients.